BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, Gomollon F, Hjortswang H, Koutroubakis I, Kulnigg S, Oldenburg B, Rampton D, Schroeder O, Stein J, Travis S, Van Assche G. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13:1545-1553. [PMID: 17985376 DOI: 10.1002/ibd.20285] [Cited by in Crossref: 278] [Cited by in F6Publishing: 259] [Article Influence: 19.9] [Reference Citation Analysis]
Number Citing Articles
1 Dignass AU, Gasche C, Bettenworth D, Birgegård G, Danese S, Gisbert JP, Gomollon F, Iqbal T, Katsanos K, Koutroubakis I, Magro F, Savoye G, Stein J, Vavricka S; European Crohn’s and Colitis Organisation [ECCO]. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis 2015;9:211-22. [PMID: 25518052 DOI: 10.1093/ecco-jcc/jju009] [Cited by in Crossref: 245] [Cited by in F6Publishing: 209] [Article Influence: 30.6] [Reference Citation Analysis]
2 Gomollón F, Gisbert JP. Intravenous iron in digestive diseases: INTRAVENOUS IRON IN DIGESTIVE DISEASES. Transfusion Alternatives in Transfusion Medicine 2012;12:122-9. [DOI: 10.1111/j.1778-428x.2012.01170.x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Khan N, Patel D, Shah Y, Yang Y. Factors Predicting Testing and Treatment of Iron Deficiency in a Nationwide Cohort of Anemic UC Patients: . Inflammatory Bowel Diseases 2016;22:2894-901. [DOI: 10.1097/mib.0000000000000947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Kaniewska M, Bartnik W, Gonciarz M, Kłopocka M, Linke K, Małecka-Panas E, Radwan P, Reguła J, Rydzewska G. Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group Recommendations. Prz Gastroenterol 2014;9:259-63. [PMID: 25395998 DOI: 10.5114/pg.2014.46159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
5 Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM. Reply: The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery A Randomized Controlled Trial. Annals of Surgery 2018;267:e49-50. [DOI: 10.1097/sla.0000000000002056] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Dahlerup JF, Jacobsen BA, van der Woude J, Bark LÅ, Thomsen LL, Lindgren S. High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23. Scand J Gastroenterol 2016;51:1332-8. [PMID: 27326766 DOI: 10.1080/00365521.2016.1196496] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
7 Reinisch W, Staun M, Tandon RK, Altorjay I, Thillainayagam AV, Gratzer C, Nijhawan S, Thomsen LL. A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED). Am J Gastroenterol. 2013;108:1877-1888. [PMID: 24145678 DOI: 10.1038/ajg.2013.335] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 9.3] [Reference Citation Analysis]
8 Danese S, Hoffman C, Vel S, Greco M, Szabo H, Wilson B, Avedano L. Anaemia from a patient perspective in inflammatory bowel disease: results from the European Federation of Crohn's and Ulcerative Colitis Association's online survey. Eur J Gastroenterol Hepatol. 2014;26:1385-1391. [PMID: 25264983 DOI: 10.1097/meg.0000000000000200] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
9 Karim S, Butler JM, Barclay ML. A 1 g dose of intravenous iron is sufficient to treat iron deficiency anaemia. Intern Med J 2020;50:1563-6. [PMID: 33354887 DOI: 10.1111/imj.15110] [Reference Citation Analysis]
10 O'Connor K, Goldberg LJ. Nutrition and hair. Clin Dermatol 2021;39:809-18. [PMID: 34785008 DOI: 10.1016/j.clindermatol.2021.05.008] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Frigstad SO, Høivik ML, Jahnsen J, Cvancarova M, Grimstad T, Berset IP, Huppertz-Hauss G, Hovde Ø, Bernklev T, Moum B, Jelsness-Jørgensen LP. Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients. World J Gastroenterol 2018; 24(29): 3293-3301 [PMID: 30090009 DOI: 10.3748/wjg.v24.i29.3293] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
12 De Franceschi L, Iolascon A, Taher A, Cappellini MD. Clinical management of iron deficiency anemia in adults: Systemic review on advances in diagnosis and treatment. Eur J Intern Med 2017;42:16-23. [PMID: 28528999 DOI: 10.1016/j.ejim.2017.04.018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 8.2] [Reference Citation Analysis]
13 Mantadakis E. Advances in Pediatric Intravenous Iron Therapy: Intravenous Iron Therapy in Children. Pediatr Blood Cancer 2016;63:11-6. [DOI: 10.1002/pbc.25752] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
14 Numan S, Kaluza K. Systematic review of guidelines for the diagnosis and treatment of iron deficiency anemia using intravenous iron across multiple indications. Curr Med Res Opin 2020;36:1769-82. [PMID: 32936683 DOI: 10.1080/03007995.2020.1824898] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kim B, Park SJ, Hong SP, Cheon JH, Kim TI, Kim WH. Overlooked Management and Risk Factors for Anemia in Patients with Intestinal Behçet's Disease in Actual Clinical Practice. Gut Liver 2015;9:750-5. [PMID: 25963076 DOI: 10.5009/gnl14193] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
16 Bhandari S. Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice. Ther Clin Risk Manag 2011;7:501-9. [PMID: 22241947 DOI: 10.2147/TCRM.S25882] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
17 Moon N, Figgins B, Altshuler E, Pham A, Kamel AY. Concurrent zinc and vitamin B6 deficiencies in acutely exacerbated inflammatory bowel disease: Case reports. Nutr Clin Pract 2021. [PMID: 33930197 DOI: 10.1002/ncp.10665] [Reference Citation Analysis]
18 Cohen BL, Zoëga H, Shah SA, Leleiko N, Lidofsky S, Bright R, Flowers N, Law M, Moniz H, Merrick M, Sands BE. Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity. Aliment Pharmacol Ther 2014;39:811-22. [PMID: 24612278 DOI: 10.1111/apt.12659] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 9.0] [Reference Citation Analysis]
19 Song SM, Kim Y, Oh SH, Kim KM. Nutritional status and growth in Korean children with Crohn's disease: a single-center study. Gut Liver 2014;8:500-7. [PMID: 25228974 DOI: 10.5009/gnl13183] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
20 Gerasimidis K, McGrogan P, Edwards CA. The aetiology and impact of malnutrition in paediatric inflammatory bowel disease. J Hum Nutr Diet. 2011;24:313-326. [PMID: 21564345 DOI: 10.1111/j.1365-277x.2011.01171.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
21 Díaz Espallardo C, Laso Morales MJ, Colilles Calvet C, Mora López L, Roig Martínez I, Martínez Marín MT. [The multidisciplinary approach is useful for optimising preoperative haemoglobin in colorectal cancer surgery]. Cir Esp. 2011;89:392-399. [PMID: 21453911 DOI: 10.1016/j.ciresp.2011.01.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
22 Niepel D, Klag T, Malek NP, Wehkamp J. Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease. Therap Adv Gastroenterol 2018;11:1756284818769074. [PMID: 29760784 DOI: 10.1177/1756284818769074] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
23 van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, Beaugerie L, Gomollón F, Häuser W, Herrlinger K, Oldenburg B, Panes J, Portela F, Rogler G, Stein J, Tilg H, Travis S, Lindsay JO. [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)]. Rev Gastroenterol Mex 2015;80:74-106. [PMID: 25769216 DOI: 10.1016/j.rgmx.2014.10.008] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Rejler M, Tholstrup J, Elg M, Spångéus A, Gäre BA. Framework for assessing quality of care for inflammatory bowel disease in Sweden. World J Gastroenterol 2012; 18(10): 1085-1092 [PMID: 22416183 DOI: 10.3748/wjg.v18.i10.1085] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
25 Lichtenstein GR, Onken JE. Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron. Dig Dis Sci 2018;63:3009-19. [PMID: 30056562 DOI: 10.1007/s10620-018-5204-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
26 Bhagya Rao B, Koutroubakis IE, Rivers CR, Regueiro M, Swoger J, Schwartz M, Baidoo L, Hashash J, Barrie A, Dunn MA, Binion DG. Correlation of anemia status with worsening bowel damage as measured by Lémann Index in patients with Crohn's disease. Dig Liver Dis 2016;48:626-31. [PMID: 27005859 DOI: 10.1016/j.dld.2016.02.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
27 Lyseng-williamson KA, Keating GM. Ferric Carboxymaltose: A Review of its Use in Iron-Deficiency Anaemia. Drugs 2009;69:739-56. [DOI: 10.2165/00003495-200969060-00007] [Cited by in Crossref: 106] [Cited by in F6Publishing: 99] [Article Influence: 8.2] [Reference Citation Analysis]
28 Ramsey M, Krishna SG, Stanich PP, Husain S, Levine EJ, Conwell D, Hinton A, Zhang C. Inflammatory Bowel Disease Adversely Impacts Colorectal Cancer Surgery Short-term Outcomes and Health-Care Resource Utilization.Clin Transl Gastroenterol. 2017;8:e127. [PMID: 29189768 DOI: 10.1038/ctg.2017.54] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
29 Sjöberg D, Holmström T, Larsson M, Nielsen AL, Holmquist L, Rönnblom A. Anemia in a population-based IBD cohort (ICURE): still high prevalence after 1 year, especially among pediatric patients. Inflamm Bowel Dis 2014;20:2266-70. [PMID: 25268635 DOI: 10.1097/MIB.0000000000000191] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 3.9] [Reference Citation Analysis]
30 Derman R, Roman E, Modiano MR, Achebe MM, Thomsen LL, Auerbach M. A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia. Am J Hematol 2017;92:286-91. [PMID: 28052413 DOI: 10.1002/ajh.24633] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
31 Atkinson MA, Leonard MB, Herskovitz R, Baldassano RN, Denburg MR. Changes in Hepcidin and Hemoglobin After Anti-TNF-alpha Therapy in Children and Adolescents With Crohn Disease. J Pediatr Gastroenterol Nutr 2018;66:90-4. [PMID: 28604512 DOI: 10.1097/MPG.0000000000001650] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
32 Biggar P, Hahn K. Bedeutung der verschiedenen i.v.-Eisengenerationen für den medizinischen Alltag. MMW - Fortschritte der Medizin 2013;155:18-24. [DOI: 10.1007/s15006-013-0732-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Venturieri MO, Komati JTS, Lopes LHC, Sdepanian VL. Treatment with Noripurum EV ® is effective and safe in pediatric patients with inflammatory bowel disease and iron deficiency anemia. Scandinavian Journal of Gastroenterology 2019;54:198-204. [DOI: 10.1080/00365521.2019.1570326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Liang H, Jiang B, Manne S, Lissoos T, Bennett D, Dolin P. Risk factors for postoperative infection after gastrointestinal surgery among adult patients with inflammatory bowel disease: Findings from a large observational US cohort study. JGH Open 2018;2:182-90. [PMID: 30483587 DOI: 10.1002/jgh3.12072] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
35 Rostoker G, Vaziri ND. Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations. Heliyon 2019;5:e02045. [PMID: 31338466 DOI: 10.1016/j.heliyon.2019.e02045] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
36 Kordbacheh H, Baliyan V, Parakh A, Wojtkiewicz GR, Hedgire S, Harisinghani MG. Pictorial review on abdominal applications of ferumoxytol in MR imaging. Abdom Radiol 2019;44:3273-84. [DOI: 10.1007/s00261-019-02163-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
37 Warsch S, Byrnes J. Emerging causes of iron deficiency anemia refractory to oral iron supplementation. World J Gastrointest Pharmacol Ther 2013; 4(3): 49-53 [PMID: 23919216 DOI: 10.4292/wjgpt.v4.i3.49] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
38 Jimenez K, Khare V, Evstatiev R, Kulnigg-Dabsch S, Jambrich M, Strobl H, Gasche C. Increased expression of HIF2α during iron deficiency-associated megakaryocytic differentiation. J Thromb Haemost 2015;13:1113-27. [PMID: 25715026 DOI: 10.1111/jth.12884] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
39 Lugg S, Beal F, Nightingale P, Bhala N, Iqbal T. Iron treatment and inflammatory bowel disease: what happens in real practice? J Crohns Colitis. 2014;8:876-880. [PMID: 24486177 DOI: 10.1016/j.crohns.2014.01.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
40 Milovanovic S, Scaldaferri F, Canarecci S, Kheiraoui F, Ciancarella G, de Waure C, Collamati A, Schiavoni E, Gasbarrini A, Boccia S, Poscia A. Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease. Dig Liver Dis 2017;49:1098-103. [PMID: 28778820 DOI: 10.1016/j.dld.2017.06.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
41 Whaley KG, Rosen MJ. Contemporary Medical Management of Acute Severe Ulcerative Colitis. Inflamm Bowel Dis 2019;25:56-66. [PMID: 29889235 DOI: 10.1093/ibd/izy208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
42 Madrazo González Z, García Barrasa A, Rafecas Renau A. Anemia, hierro, transfusión y alternativas terapéuticas. Revisión desde una perspectiva quirúrgica. Cirugía Española 2010;88:358-68. [DOI: 10.1016/j.ciresp.2010.03.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
43 García-López S, Bocos JM, Gisbert JP, Bajador E, Chaparro M, Castaño C, García-Erce JA, Gomollón F. High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of life. Blood Transfus 2016;14:199-205. [PMID: 27177405 DOI: 10.2450/2016.0246-15] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
44 Zhu A, Kaneshiro M, Kaunitz JD. Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective. Dig Dis Sci. 2010;55:548-559. [PMID: 20108038 DOI: 10.1007/s10620-009-1108-6] [Cited by in Crossref: 89] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
45 Wiskin AE, Haggarty R, Afzal NA, Batra A, Wootton SA, Beattie RM. Nutritional perspectives of children with Crohn's disease: a single-centre cohort observation of disease activity, energy expenditure and dietary intake. Eur J Clin Nutr 2016;70:1132-7. [PMID: 27329610 DOI: 10.1038/ejcn.2016.107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
46 Bergamaschi G, Di Sabatino A, Albertini R, Ardizzone S, Biancheri P, Bonetti E, Cassinotti A, Cazzola P, Markopoulos K, Massari A. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. Haematologica. 2010;95:199-205. [PMID: 19815838 DOI: 10.3324/haematol.2009.009985] [Cited by in Crossref: 100] [Cited by in F6Publishing: 93] [Article Influence: 7.7] [Reference Citation Analysis]
47 Ionescu A, Sharma A, Kundnani NR, Mihăilescu A, David VL, Bedreag O, Săndesc D, Dinu AR, Săndesc MA, Albulescu N, Drăgoi RG. Intravenous iron infusion as an alternative to minimize blood transfusion in peri-operative patients. Sci Rep 2020;10:18403. [PMID: 33110237 DOI: 10.1038/s41598-020-75535-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Koch TA, Myers J, Goodnough LT. Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations. Anemia. 2015;2015:763576. [PMID: 26257955 DOI: 10.1155/2015/763576] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
49 Powell JJ, Cook WB, Hutchinson C, Tolkien Z, Chatfield M, Pereira DIa, Lomer MC. Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease. Nutr Metab (Lond). 2013;10:9. [PMID: 23320878 DOI: 10.1186/1743-7075-10-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
50 Karlsson T, Cherif H. Effect of Intravenous Iron Supplementation on Iron Stores in Non-Anemic Iron-Deficient Patients with Hereditary Hemorrhagic Telangiectasia. Hematol Rep 2016;8:6348. [PMID: 27103980 DOI: 10.4081/hr.2016.6348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
51 Conklin LS, Oliva-Hemker M. Nutritional considerations in pediatric inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2010;4:305-317. [PMID: 20528118 DOI: 10.1586/egh.10.23] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
52 Auerbach M, Deloughery T. Single-dose intravenous iron for iron deficiency: a new paradigm. Hematology Am Soc Hematol Educ Program 2016;2016:57-66. [PMID: 27913463 DOI: 10.1182/asheducation-2016.1.57] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]
53 Kormi SMA, Seghatchian J. Taming the immune system through transfusion in oncology patients. Transfus Apher Sci 2017;56:310-6. [PMID: 28651910 DOI: 10.1016/j.transci.2017.05.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
54 Bjørklund G, Aaseth J, Skalny AV, Suliburska J, Skalnaya MG, Nikonorov AA, Tinkov AA. Interactions of iron with manganese, zinc, chromium, and selenium as related to prophylaxis and treatment of iron deficiency. Journal of Trace Elements in Medicine and Biology 2017;41:41-53. [DOI: 10.1016/j.jtemb.2017.02.005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 10.6] [Reference Citation Analysis]
55 Sukumaran A, James J, Janardhan HP, Amaladas A, Suresh LM, Danda D, Jeyeseelan V, Ramakrishna BS, Jacob M. Expression of iron-related proteins in the duodenum is up-regulated in patients with chronic inflammatory disorders. Br J Nutr 2014;111:1059-68. [PMID: 24160450 DOI: 10.1017/S0007114513003334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
56 Bierbaum M, Grad MO, Wulff H, Kewenig S, Schöffski O. [Development and implementation of an integrated care pathway at the POLIKUM health centers using the example of anemia]. Internist (Berl) 2014;55:470-7. [PMID: 24577343 DOI: 10.1007/s00108-014-3462-5] [Reference Citation Analysis]
57 Rogler G, Vavricka S. Anemia in inflammatory bowel disease: an under-estimated problem? Front Med (Lausanne). 2014;1:58. [PMID: 25646159 DOI: 10.3389/fmed.2014.00058] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
58 Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, Beaugerie L, Gomollón F, Häuser W, Herrlinger K, Oldenburg B, Panes J, Portela F, Rogler G, Stein J, Tilg H, Travis S, Lindsay JO. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations. Journal of Crohn's and Colitis 2013;7:1-33. [DOI: 10.1016/j.crohns.2012.09.005] [Cited by in Crossref: 332] [Cited by in F6Publishing: 270] [Article Influence: 36.9] [Reference Citation Analysis]
59 Gybel-Brask M, Seeberg J, Thomsen LL, Johansson PI. Intravenous iron isomaltoside improves hemoglobin concentration and iron stores in female iron-deficient blood donors: a randomized double-blind placebo-controlled clinical trial. Transfusion 2018;58:974-81. [PMID: 29424441 DOI: 10.1111/trf.14521] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
60 Svenson N, Bailey J, Durairaj S, Dempsey-Hibbert N. A simplified diagnostic pathway for the differential diagnosis of iron deficiency anaemia and anaemia of chronic disease. Int J Lab Hematol 2021. [PMID: 34288431 DOI: 10.1111/ijlh.13666] [Reference Citation Analysis]
61 Fornaro R, Caratto M, Barbruni G, Fornaro F, Salerno A, Giovinazzo D, Sticchi C, Caratto E. Surgical and medical treatment in patients with acute severe ulcerative colitis. J Dig Dis. 2015;16:558-567. [PMID: 26315728 DOI: 10.1111/1751-2980.12278] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
62 Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica. 2010;95:175-178. [PMID: 20139387 DOI: 10.3324/haematol.2009.017046] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
63 Danko I. Response of Iron Deficiency Anemia to Intravenous Iron Sucrose in Pediatric Inflammatory Bowel Disease. J Pediatr Pharmacol Ther 2016;21:162-8. [PMID: 27199624 DOI: 10.5863/1551-6776-21.2.162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
64 Richards T, Clevenger B, Keidan J, Collier T, Klein AA, Anker SD, Kelly JD. PREVENTT: preoperative intravenous iron to treat anaemia in major surgery: study protocol for a randomised controlled trial. Trials 2015;16:254. [PMID: 26041028 DOI: 10.1186/s13063-015-0774-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
65 Mullin GE. Micronutrients and inflammatory bowel disease. Nutr Clin Pract. 2012;27:136-137. [PMID: 22223669 DOI: 10.1177/0884533611433436] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
66 Grimstad T, Norheim KB, Isaksen K, Leitao K, Hetta AK, Carlsen A, Karlsen LN, Skoie IM, Gøransson L, Harboe E, Aabakken L, Omdal R. Fatigue in Newly Diagnosed Inflammatory Bowel Disease. J Crohns Colitis 2015;9:725-30. [PMID: 25994356 DOI: 10.1093/ecco-jcc/jjv091] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
67 Jimenez K, Gasche C, Auerbach M. On both sides of the ocean. Blood Transfus 2016;14:197-8. [PMID: 27177396 DOI: 10.2450/2016.0304-15] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
68 Yarjou S, Sadeghpour O, Nazem E, Emami AH. Liver function and anemia pathogenesis in Iranian traditional medicine. Iran Red Crescent Med J 2015;17:e17099. [PMID: 25763255 DOI: 10.5812/ircmj.17099] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
69 Papay P, Hackner K, Vogelsang H, Novacek G, Primas C, Reinisch W, Eser A, Mikulits A, Mayr WR, Körmöczi GF. High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease. Am J Med 2012;125:717.e1-8. [PMID: 22560809 DOI: 10.1016/j.amjmed.2011.11.028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
70 García-Erce JA, Gomollón F, Muñoz M. Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases. World J Gastroenterol 2009; 15(37): 4686-4694 [PMID: 19787832 DOI: 10.3748/wjg.15.4686] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
71 Liu S, Ren J, Hong Z, Yan D, Gu G, Han G, Wang G, Ren H, Chen J, Li J. Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn’s disease: a prospective cohort study. Nutr Clin Pract. 2013;28:120-127. [PMID: 23064018 DOI: 10.1177/0884533612462744] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
72 Cançado RD, Muñoz M. Intravenous iron therapy: how far have we come? Rev Bras Hematol Hemoter 2011;33:461-9. [PMID: 23049364 DOI: 10.5581/1516-8484.20110123] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
73 Reinisch W, Altorjay I, Zsigmond F, Primas C, Vogelsang H, Novacek G, Reinisch S, Thomsen LL. A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease. Scand J Gastroenterol 2015;50:1226-33. [PMID: 25900645 DOI: 10.3109/00365521.2015.1031168] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
74 Hart AL, Ng SC. Review article: the optimal medical management of acute severe ulcerative colitis. Aliment Pharmacol Ther 2010;32:615-27. [PMID: 20626381 DOI: 10.1111/j.1365-2036.2010.04392.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
75 Gomollón F, García-López S, Sicilia B, Gisbert JP, Hinojosa J; en representació del Grupo Espa˜nol de Trabajode Enfermedad de Crohn y Colitis Ulcerosa or Spanish Group for Working on Crohn’sDisease and Ulcerative Colitis (GETECCU). [Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU]. Gastroenterol Hepatol 2013;36:e1-47. [PMID: 24215088 DOI: 10.1016/j.gastrohep.2012.11.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
76 Hwang C, Ross V, Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm Bowel Dis. 2012;18:1961-1981. [PMID: 22488830 DOI: 10.1002/ibd.22906] [Cited by in Crossref: 119] [Cited by in F6Publishing: 100] [Article Influence: 11.9] [Reference Citation Analysis]
77 Geisel T, Martin J, Schulze B, Schaefer R, Bach M, Virgin G, Stein J. An etiologic profile of anemia in 405 geriatric patients. Anemia. 2014;2014:932486. [PMID: 24707396 DOI: 10.1155/2014/932486] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
78 van Rheenen PF. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control. Inflamm Bowel Dis. 2012;18:2018-2025. [PMID: 22275341 DOI: 10.1002/ibd.22896] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
79 Bailie GR. Comparison of rates of reported adverse events associated with i.v. iron products in the United States. American Journal of Health-System Pharmacy 2012;69:310-20. [DOI: 10.2146/ajhp110262] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
80 Kumar A, Brookes MJ. Iron Therapy in Inflammatory Bowel Disease. Nutrients 2020;12:E3478. [PMID: 33198376 DOI: 10.3390/nu12113478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
81 Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017;11:649-670. [PMID: 28158501 DOI: 10.1093/ecco-jcc/jjx008] [Cited by in Crossref: 682] [Cited by in F6Publishing: 563] [Article Influence: 170.5] [Reference Citation Analysis]
82 Ferrer-Barceló L, Sanchis Artero L, Sempere García-Argüelles J, Canelles Gamir P, P Gisbert J, Ferrer-Arranz LM, Monzó Gallego A, Plana Campos L, Huguet Malavés JM, Luján Sanchis M, Ruiz Sánchez L, Barceló Cerdá S, Medina Chuliá E. Randomised clinical trial: intravenous vs oral iron for the treatment of anaemia after acute gastrointestinal bleeding. Aliment Pharmacol Ther 2019;50:258-68. [PMID: 31197861 DOI: 10.1111/apt.15327] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
83 Koduru P, Abraham BP. The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease. Therap Adv Gastroenterol 2016;9:76-85. [PMID: 26770269 DOI: 10.1177/1756283X15616577] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
84 Michailidou M, Nfonsam VN. Preoperative anemia and outcomes in patients undergoing surgery for inflammatory bowel disease. Am J Surg 2018;215:78-81. [PMID: 28359559 DOI: 10.1016/j.amjsurg.2017.02.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
85 Varcher M, Zisimopoulou S, Braillard O, Favrat B, Junod Perron N. Iron deficiency intravenous substitution in a Swiss academic primary care division: analysis of practices. Int J Gen Med 2016;9:221-7. [PMID: 27445502 DOI: 10.2147/IJGM.S107821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
86 Tulewicz-Marti EM, Lewandowski K, Szczubełek M, Rydzewska G. Management of anaemia in patients with inflammatory bowel disease - results of a questionnaire among Polish healthcare professionals. Prz Gastroenterol 2021;16:89-94. [PMID: 33986893 DOI: 10.5114/pg.2021.104738] [Reference Citation Analysis]
87 Ince MN, Elliott DE. Effective Use of the Laboratory in the Management of Patients with Inflammatory Bowel Diseases. Gastroenterol Clin North Am 2019;48:237-58. [PMID: 31046973 DOI: 10.1016/j.gtc.2019.02.006] [Reference Citation Analysis]
88 Kulnigg-Dabsch S, Evstatiev R, Dejaco C, Gasche C. Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia. PLoS One. 2012;7:e34520. [PMID: 22506024 DOI: 10.1371/journal.pone.0034520] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
89 Avni T, Bieber A, Steinmetz T, Leibovici L, Gafter-Gvili A. Treatment of anemia in inflammatory bowel disease--systematic review and meta-analysis. PLoS One 2013;8:e75540. [PMID: 24312441 DOI: 10.1371/journal.pone.0075540] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
90 Akkermans MD, Vreugdenhil M, Hendriks DM, van den Berg A, Schweizer JJ, van Goudoever JB, Brus F. Iron Deficiency in Inflammatory Bowel Disease: The Use of Zincprotoporphyrin and Red Blood Cell Distribution Width. Journal of Pediatric Gastroenterology & Nutrition 2017;64:949-54. [DOI: 10.1097/mpg.0000000000001406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
91 Moreno Chulilla JA, Romero Colás MS, Gutiérrez Martín M. Classification of anemia for gastroenterologists. World J Gastroenterol 2009; 15(37): 4627-4637 [PMID: 19787825 DOI: 10.3748/wjg.15.4627] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
92 Basson A. Nutrition management in the adult patient with Crohn’s disease. South African Journal of Clinical Nutrition 2016;25:164-72. [DOI: 10.1080/16070658.2012.11734423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
93 Goyal A, Zheng Y, Albenberg LG, Stoner NL, Hart L, Alkhouri R, Hampson K, Ali S, Cho-Dorado M, Goyal RK, Grossman A. Anemia in Children With Inflammatory Bowel Disease: A Position Paper by the IBD Committee of the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2020;71:563-82. [PMID: 32947565 DOI: 10.1097/MPG.0000000000002885] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
94 Kanamori Y, Murakami M, Sugiyama M, Hashimoto O, Matsui T, Funaba M. Hepcidin and IL-1β. Vitam Horm 2019;110:143-56. [PMID: 30798809 DOI: 10.1016/bs.vh.2019.01.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
95 Cançado RD, de Figueiredo PO, Olivato MC, Chiattone CS. Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia. Rev Bras Hematol Hemoter 2011;33:439-43. [PMID: 23049360 DOI: 10.5581/1516-8484.20110119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
96 Kim S, Koh H. Nutritional aspect of pediatric inflammatory bowel disease: its clinical importance. Korean J Pediatr. 2015;58:363-368. [PMID: 26576179 DOI: 10.3345/kjp.2015.58.10.363] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
97 Ott C, Liebold A, Takses A, Strauch UG, Obermeier F. High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort. Gastroenterol Res Pract. 2012;2012:595970. [PMID: 22899905 DOI: 10.1155/2012/595970] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
98 Widbom L, Ekblom K, Karling P, Hultdin J. Patients developing inflammatory bowel disease have iron deficiency and lower plasma ferritin years before diagnosis: a nested case-control study. Eur J Gastroenterol Hepatol 2020;32:1147-53. [PMID: 32541236 DOI: 10.1097/MEG.0000000000001816] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Sobrado CW, Cançado RD, Sobrado LF, Frugis MO, Sobrado MF. TREATMENT OF ANEMIA AND IMPROVEMENT OF QUALITY OF LIFE AMONG PATIENTS WITH CROHN'S DISEASE: experience using ferric carboxymaltose. Arq Gastroenterol 2015;52:255-9. [DOI: 10.1590/s0004-28032015000400002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
100 Kim KO. [Management of anemia in patients with inflammatory bowel disease]. Korean J Gastroenterol 2015;65:145-50. [PMID: 25797377 DOI: 10.4166/kjg.2015.65.3.145] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
101 Abhyankar A, Moss AC. Iron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis 2015;21:1976-81. [PMID: 25844962 DOI: 10.1097/MIB.0000000000000386] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
102 Patel D, Trivedi C, Khan N. Management of Anemia in Patients with Inflammatory Bowel Disease (IBD). Curr Treat Options Gastroenterol 2018;16:112-28. [PMID: 29404920 DOI: 10.1007/s11938-018-0174-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
103 Matusiewicz M, Neubauer K, Lewandowska P, Gamian A, Krzystek-Korpacka M. Reduced Transferrin Levels in Active Inflammatory Bowel Disease. Biomed Res Int 2017;2017:9541370. [PMID: 29226154 DOI: 10.1155/2017/9541370] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
104 Bager P, Dahlerup JF. The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective. J Crohns Colitis. 2010;4:427-430. [PMID: 21122539 DOI: 10.1016/j.crohns.2010.01.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
105 Van Assche G. Intravenous iron for the treatment of iron deficiency in IBD: the pendulum is swinging. Am J Gastroenterol 2013;108:1889-90. [PMID: 24300864 DOI: 10.1038/ajg.2013.400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
106 McDonagh T, Macdougall IC. Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral? Eur J Heart Fail. 2015;17:248-262. [PMID: 25639592 DOI: 10.1002/ejhf.236] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 10.9] [Reference Citation Analysis]
107 Madrazo González Z, García Barrasa A, Rodríguez Lorenzo L, Rafecas Renau A. Hierro intravenoso. Cirugía Española 2009;86:196-203. [DOI: 10.1016/j.ciresp.2009.05.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
108 Clark SF. Iron deficiency anemia: diagnosis and management. Curr Opin Gastroenterol 2009;25:122-8. [PMID: 19262200 DOI: 10.1097/MOG.0b013e32831ef1cd] [Cited by in Crossref: 92] [Cited by in F6Publishing: 26] [Article Influence: 7.1] [Reference Citation Analysis]
109 Bokemeyer B. Addressing unmet needs in inflammatory bowel disease. Drug Discovery Today 2015;20:1037-9. [DOI: 10.1016/j.drudis.2015.07.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
110 Parian AM, Mullin GE, Langhorst J, Brown AC. Inflammatory Bowel Disease. Integrative Medicine. Elsevier; 2018. pp. 501-516.e8. [DOI: 10.1016/b978-0-323-35868-2.00050-5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
111 Lindgren S, Wikman O, Befrits R, Blom H, Eriksson A, Grännö C, Ung KA, Hjortswang H, Lindgren A, Unge P. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol. 2009;44:838-845. [PMID: 19330567 DOI: 10.1080/00365520902839667] [Cited by in Crossref: 96] [Cited by in F6Publishing: 98] [Article Influence: 8.0] [Reference Citation Analysis]
112 Syed S, Kugathasan S, Kumar A, Prince J, Schoen BT, McCracken C, Ziegler TR, Suchdev PS. Use of Reticulocyte Hemoglobin Content in the Assessment of Iron Deficiency in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2017;64:713-20. [PMID: 27429427 DOI: 10.1097/MPG.0000000000001335] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
113 Sabe R, Vatsayan A, Mahran A, Khalili AS, Ahuja S, Sferra TJ. Safety and Efficacy of Intravenous Iron Sucrose for Iron-Deficiency Anemia in Children and Adolescents With Inflammatory Bowel Disease. Glob Pediatr Health 2019;6:2333794X19870981. [PMID: 31453270 DOI: 10.1177/2333794X19870981] [Reference Citation Analysis]
114 Wenger S, Nikolaus S, Howaldt S, Bokemeyer B, Sturm A, Preiss JC, Schoepfer AM, Stallmach A, Schmidt C. Predictors for subsequent need for immunosuppressive therapy in early Crohn's disease. Journal of Crohn's and Colitis 2012;6:21-8. [DOI: 10.1016/j.crohns.2011.06.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
115 Gozzard D. When is high-dose intravenous iron repletion needed? Assessing new treatment options. Drug Des Devel Ther 2011;5:51-60. [PMID: 21340038 DOI: 10.2147/DDDT.S15817] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
116 Frigstad SO, Høivik ML, Jahnsen J, Cvancarova M, Grimstad T, Berset IP, Huppertz-Hauss G, Hovde Ø, Bernklev T, Moum B, Jelsness-Jørgensen LP. Pain Severity and Vitamin D Deficiency in IBD Patients. Nutrients 2019;12:E26. [PMID: 31877637 DOI: 10.3390/nu12010026] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
117 Shah Y, Patel D, Khan N. Iron deficiency anemia in IBD: an overlooked comorbidity. Expert Rev Gastroenterol Hepatol 2021;15:771-81. [PMID: 33691543 DOI: 10.1080/17474124.2021.1900730] [Reference Citation Analysis]
118 Koutroubakis IE, Ramos-Rivers C, Regueiro M, Koutroumpakis E, Click B, Schoen RE, Hashash JG, Schwartz M, Swoger J, Baidoo L, Barrie A, Dunn MA, Binion DG. Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2015;13:1760-6. [PMID: 25862987 DOI: 10.1016/j.cgh.2015.03.029] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
119 Beguin Y, Jaspers A. Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. Expert Opin Pharmacother 2014;15:2087-103. [PMID: 25186219 DOI: 10.1517/14656566.2014.953928] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
120 Ogawa C, Tsuchiya K, Maeda K. Reticulocyte hemoglobin content. Clinica Chimica Acta 2020;504:138-45. [DOI: 10.1016/j.cca.2020.01.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
121 Vavricka SR, Schoepfer AM, Safroneeva E, Rogler G, Schwenkglenks M, Achermann R. A Shift From Oral to Intravenous Iron Supplementation Therapy Is Observed Over Time in a Large Swiss Cohort of Patients With Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2013;19:840-6. [DOI: 10.1097/mib.0b013e31827febbb] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
122 Alves RA, Miszputen SJ, Figueiredo MS. Anemia in inflammatory bowel disease: prevalence, differential diagnosis and association with clinical and laboratory variables. Sao Paulo Med J 2014;132:140-6. [PMID: 24760213 DOI: 10.1590/1516-3180.2014.1323568] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
123 Kearns J, Jacob SG. Real-world evaluation of an intravenous iron service for the treatment of iron deficiency in patients with gastroenterological disorders. Frontline Gastroenterol 2021;12:265-71. [PMID: 34249310 DOI: 10.1136/flgastro-2020-101406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Evstatiev R, Alexeeva O, Bokemeyer B, Chopey I, Felder M, Gudehus M, Iqbal T, Khalif I, Marteau P, Stein J. Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013;11:269-277. [PMID: 23078888 DOI: 10.1016/j.cgh.2012.10.013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 6.1] [Reference Citation Analysis]
125 Friedman AJ, Shander A, Martin SR, Calabrese RK, Ashton ME, Lew I, Seid MH, Goodnough LT. Iron Deficiency Anemia in Women: A Practical Guide to Detection, Diagnosis, and Treatment. Obstetrical & Gynecological Survey 2015;70:342-53. [DOI: 10.1097/ogx.0000000000000172] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
126 Dibb M, Subramanian S. Anaemia in inflammatory bowel disease. Frontline Gastroenterol 2014;5:190-6. [PMID: 28839769 DOI: 10.1136/flgastro-2013-100388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
127 Guagnozzi D, Lucendo AJ. Anemia in inflammatory bowel disease: a neglected issue with relevant effects. World J Gastroenterol. 2014;20:3542-3551. [PMID: 24707137 DOI: 10. 3748/wjg.v20.i13.3542] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Guagnozzi D, Lucendo AJ. Anemia in inflammatory bowel disease: A neglected issue with relevant effects. World J Gastroenterol 2014; 20(13): 3542-3551 [PMID: 24707137 DOI: 10.3748/wjg.v20.i13.3542] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
129 Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM. The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial. Ann Surg 2016;264:41-6. [PMID: 26817624 DOI: 10.1097/SLA.0000000000001646] [Cited by in Crossref: 139] [Cited by in F6Publishing: 45] [Article Influence: 27.8] [Reference Citation Analysis]
130 Nguyen PH, Gonzalez-casanova I, Nguyen H, Pham H, Truong TV, Nguyen S, Martorell R, Ramakrishnan U. Multicausal etiology of anemia among women of reproductive age in Vietnam. Eur J Clin Nutr 2015;69:107-13. [DOI: 10.1038/ejcn.2014.181] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
131 Toblli JE, Cao G, Angerosa M. Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats. Drug Des Devel Ther 2015;9:2585-97. [PMID: 26005335 DOI: 10.2147/DDDT.S81863] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
132 Gomollón F, Gisbert JP, García-Erce JA. Intravenous iron in digestive diseases: a clinical (re)view. Ther Adv Chronic Dis. 2010;1:67-75. [PMID: 23251730 DOI: 10.1177/2040622310373675] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
133 Befrits R, Wikman O, Blomquist L, Hjortswang H, Hammarlund P, Bajor A, Klintman D, Blom H. Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life. Scandinavian Journal of Gastroenterology 2013;48:1027-32. [DOI: 10.3109/00365521.2013.819442] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
134 Bermejo San José F. ¿Realmente sirve para algo el hierro intravenoso en el tratamiento de la enfermedad inflamatoria intestinal? ¿No es más sencillo y más barato el hierro oral? Gastroenterología y Hepatología 2009;32:63-4. [DOI: 10.1016/j.gastrohep.2008.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
135 Abbati G, Incerti F, Boarini C, Pileri F, Bocchi D, Ventura P, Buzzetti E, Pietrangelo A. Safety and efficacy of sucrosomial iron in inflammatory bowel disease patients with iron deficiency anemia. Intern Emerg Med 2019;14:423-31. [PMID: 30499070 DOI: 10.1007/s11739-018-1993-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
136 Herrera-deGuise C, Casellas F, Robles V, Navarro E, Borruel N. Iron Deficiency in the Absence of Anemia Impairs the Perception of Health-Related Quality of Life of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:1450-1455. [PMID: 27057682 DOI: 10.1097/mib.0000000000000768] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
137 Tsai MS, Chen HP, Hung CM, Lee PH, Lin CL, Kao CH. Hospitalization for Inflammatory Bowel Disease is Associated with Increased Risk of Breast Cancer: A Nationwide Cohort Study of an Asian Population. Ann Surg Oncol 2015;22:1996-2002. [PMID: 25354573 DOI: 10.1245/s10434-014-4198-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
138 Valério de Azevedo S, Maltez C, Lopes AI. Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study. Scandinavian Journal of Gastroenterology 2017;52:29-33. [DOI: 10.1080/00365521.2016.1224381] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
139 Rizvi S, Schoen RE. Response to Michael. American Journal of Gastroenterology 2012;107:950-1. [DOI: 10.1038/ajg.2012.96] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
140 Jacobson-Kelly AE, Stanek JR, Powers JM, Dotson JL, O'Brien SH. Trends in Anemia, Iron, Therapy, and Transfusion in Hospitalized Pediatric Patients with Inflammatory Bowel Disease. J Pediatr 2020;222:141-145.e1. [PMID: 32444225 DOI: 10.1016/j.jpeds.2020.02.071] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
141 Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, Bokemeyer B, Chopey IV, Gutzwiller FS, Riopel L, Gasche C. FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease. Gastroenterology 2011;141:846-853.e2. [DOI: 10.1053/j.gastro.2011.06.005] [Cited by in Crossref: 201] [Cited by in F6Publishing: 181] [Article Influence: 18.3] [Reference Citation Analysis]
142 Reinisch W, Staun M, Bhandari S, Muñoz M. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. J Crohns Colitis 2013;7:429-40. [PMID: 22917870 DOI: 10.1016/j.crohns.2012.07.031] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
143 Red Blood Cell Diseases (Anemia) Group, Chinese Society of Hematology, Chinese Medical Association. [Chinese expert consensus on the application of intravenous iron (2019)]. Zhonghua Xue Ye Xue Za Zhi 2019;40:358-62. [PMID: 31207697 DOI: 10.3760/cma.j.issn.0253-2727.2019.05.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
144 Donnellan CF, Yann LH, Lal S. Nutritional management of Crohn’s disease. Therap Adv Gastroenterol. 2013;6:231-242. [PMID: 23634187 DOI: 10.1177/1756283x13477715] [Cited by in Crossref: 54] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
145 Powers JM, Buchanan GR. Diagnosis and Management of Iron Deficiency Anemia. Hematology/Oncology Clinics of North America 2014;28:729-45. [DOI: 10.1016/j.hoc.2014.04.007] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 5.9] [Reference Citation Analysis]
146 Auerbach M. Oral or IV iron in inflammatory bowel disease. Am J Gastroenterol 2012;107:950; author reply 950-1. [PMID: 22664849 DOI: 10.1038/ajg.2012.94] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
147 Bermejo F, Algaba A, Guerra I, Chaparro M, De-La-Poza G, Valer P, Piqueras B, Bermejo A, García-Alonso J, Pérez MJ. Should we monitor vitamin B12 and folate levels in Crohn’s disease patients? Scand J Gastroenterol. 2013;48:1272-1277. [PMID: 24063425 DOI: 10.3109/00365521.2013.836752] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
148 Nordfjeld K, Andreasen H, Thomsen LL. Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease. Drug Des Devel Ther 2012;6:43-51. [PMID: 22419860 DOI: 10.2147/DDDT.S30015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 0.1] [Reference Citation Analysis]
149 Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, Dahlerup JF. High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2-year follow-up study. Scand J Gastroenterol. 2013;48:1286-1293. [PMID: 24073709 DOI: 10.3109/00365521.2013.838605] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
150 Wang M, Tang W, Xin H, Zhu YZ. S-Propargyl-Cysteine, a Novel Hydrogen Sulfide Donor, Inhibits Inflammatory Hepcidin and Relieves Anemia of Inflammation by Inhibiting IL-6/STAT3 Pathway. PLoS One 2016;11:e0163289. [PMID: 27649298 DOI: 10.1371/journal.pone.0163289] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
151 Gisbert JP, Bermejo F, Pajares R, Pérez-Calle JL, Rodríguez M, Algaba A, Mancenido N, de la Morena F, Carneros JA, McNicholl AG. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis. 2009;15:1485-1491. [PMID: 19408339 DOI: 10.1002/ibd.20925] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 6.3] [Reference Citation Analysis]
152 Akhuemonkhan E, Parian A, Miller K, Hanauer S, Hutfless S. Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010-2014. BMJ Open Gastroenterol. 2017;4:e000155. [PMID: 28944071 DOI: 10.1136/bmjgast-2017-000155] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
153 Iqbal T, Stein J, Sharma N, Kulnigg-Dabsch S, Vel S, Gasche C. Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia. Dig Dis Sci 2015;60:1375-81. [PMID: 25501922 DOI: 10.1007/s10620-014-3460-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
154 Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, Garcia LC, Sambuelli AM, D’Haens G, Gasche C. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol. 2008;103:1182-1192. [PMID: 18371137 DOI: 10.1111/j.1572-0241.2007.01744.x] [Cited by in Crossref: 202] [Cited by in F6Publishing: 204] [Article Influence: 14.4] [Reference Citation Analysis]
155 Oustamanolakis P, Koutroubakis IE, Kouroumalis EA. Diagnosing anemia in inflammatory bowel disease: beyond the established markers. J Crohns Colitis. 2011;5:381-391. [PMID: 21939910 DOI: 10.1016/j.crohns.2011.03.010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
156 Koutroubakis IE, Ramos-Rivers C, Regueiro M, Koutroumpakis E, Click B, Schwartz M, Swoger J, Baidoo L, Hashash JG, Barrie A, Dunn MA, Binion DG. The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2015;21:1587-93. [PMID: 25933393 DOI: 10.1097/MIB.0000000000000417] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 4.2] [Reference Citation Analysis]
157 Sedano R, Quera R, Simian D, Yarur AJ. An approach to acute severe ulcerative colitis. Expert Rev Gastroenterol Hepatol 2019;13:943-55. [PMID: 31648574 DOI: 10.1080/17474124.2019.1681974] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
158 Gasche C, Ahmad T, Tulassay Z, Baumgart DC, Bokemeyer B, Büning C, Howaldt S, Stallmach A; AEGIS Study Group. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. Inflamm Bowel Dis. 2015;21:579-588. [PMID: 25545376 DOI: 10.1097/mib.0000000000000314] [Cited by in Crossref: 75] [Cited by in F6Publishing: 38] [Article Influence: 10.7] [Reference Citation Analysis]
159 Lee TW, Kolber MR, Fedorak RN, van Zanten SV. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis. 2012;6:267-275. [PMID: 22405161 DOI: 10.1016/j.crohns.2011.09.010] [Cited by in Crossref: 95] [Cited by in F6Publishing: 78] [Article Influence: 8.6] [Reference Citation Analysis]
160 Hedenus M, Birgegård G. The role of iron supplementation during epoietin treatment for cancer-related anemia. Med Oncol 2009;26:105-15. [DOI: 10.1007/s12032-008-9072-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
161 O'Sullivan M. Symposium on 'The challenge of translating nutrition research into public health nutrition'. Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease'. Nutrition in Crohn's disease. Proc Nutr Soc. 2009;68:127-134. [PMID: 19208269 DOI: 10.1017/s0029665109001025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
162 Elli L, Norsa L, Zullo A, Carroccio A, Girelli C, Oliva S, Romano C, Leandro G, Bellini M, Marmo R, Soncini M, Monica F, De Francesco V, Paulon E, Cappellini MD, Motta I, Ferretti F, Orlando S, Mansueto P, Buscarini E, Manfredi G, Agostoni C, Tomba C, Cannizzaro R. Diagnosis of chronic anaemia in gastrointestinal disorders: A guideline by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) and the Italian Society of Paediatric Gastroenterology Hepatology and Nutrition (SIGENP). Dig Liver Dis 2019;51:471-83. [PMID: 30850345 DOI: 10.1016/j.dld.2019.01.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
163 Rejler M, Tholstrup J, Andersson-Gäre B, Spångéus A. Low prevalence of anemia in inflammatory bowel disease: a population-based study in Sweden. Scand J Gastroenterol 2012;47:937-42. [PMID: 22571405 DOI: 10.3109/00365521.2012.672590] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
164 Van Biervliet S, Smets F, Hofmann I, Degreef E, Hauser B, Bontems P, Vande Velde S, Arts W, Paquot I, Alliet P, Bossuyt P, Louis E, Baert F, Bauraind O, Rahier JF, Veereman G. The course of anaemia in children and adolescents with Crohn's disease included in a prospective registry. Int J Colorectal Dis 2015;30:51-6. [PMID: 25354967 DOI: 10.1007/s00384-014-2042-4] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
165 Spicher K, Brendler-schwaab S, Schlösser C, Catarinolo M, Fütterer S, Langguth P, Enzmann H. Differences in tissue distribution of iron from various clinically used intravenous iron complexes in fetal avian heart and liver. Regulatory Toxicology and Pharmacology 2015;73:65-72. [DOI: 10.1016/j.yrtph.2015.06.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
166 Voegtlin M, Vavricka SR, Schoepfer AM, Straumann A, Voegtlin J, Rogler G, Ballabeni P, Pittet V, Buser A, Fried M, Beglinger C; Swiss IBD Cohort Study. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. J Crohns Colitis 2010;4:642-8. [PMID: 21122574 DOI: 10.1016/j.crohns.2010.07.008] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
167 Fang W, Kenny R, Rizvi QU, McMahon LP, Garg M. Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status. BMC Gastroenterol 2020;20:183. [PMID: 32522150 DOI: 10.1186/s12876-020-01298-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
168 Blumenstein I, Dignass A, Vollmer S, Klemm W, Weber-Mangal S, Stein J. Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: the German AnaemIBD Study. J Crohns Colitis. 2014;8:1308-1314. [PMID: 24721157 DOI: 10.1016/j.crohns.2014.03.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
169 Muñoz M, Gómez-Ramírez S, García-Erce JA. Intravenous iron in inflammatory bowel disease. World J Gastroenterol 2009; 15(37): 4666-4674 [PMID: 19787830 DOI: 10.3748/wjg.15.4666] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
170 Wiskin AE, Fleming BJ, Wootton SA, Beattie RM. Anaemia and iron deficiency in children with inflammatory bowel disease. Journal of Crohn's and Colitis 2012;6:687-91. [DOI: 10.1016/j.crohns.2011.12.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
171 Gomollón F, Gisbert JP. Current Management of Iron Deficiency Anemia in Inflammatory Bowel Diseases: A Practical Guide. Drugs 2013;73:1761-70. [DOI: 10.1007/s40265-013-0131-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
172 Filmann N, Rey J, Schneeweiss S, Ardizzone S, Bager P, Bergamaschi G, Koutroubakis I, Lindgren S, Morena Fde L, Moum B. Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysis. Inflamm Bowel Dis. 2014;20:936-945. [PMID: 24572205 DOI: 10.1097/01.mib.0000442728.74340.fd] [Cited by in Crossref: 78] [Cited by in F6Publishing: 39] [Article Influence: 11.1] [Reference Citation Analysis]
173 Kalra PA, Bhandari S. Safety of intravenous iron use in chronic kidney disease. Curr Opin Nephrol Hypertens 2016;25:529-35. [PMID: 27557350 DOI: 10.1097/MNH.0000000000000263] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
174 Rubio-terrés C, López ÁF, Montero AF, Vega JML, Castelao AM, Gisbert JP, Valera MQ, Baines JPO. Análisis farmacoeconómico del tratamiento de la deficiencia de hierro con hierro carboximaltosa (Ferinject®) en España. Pharmacoecon Span Res Artic 2010;7:109-17. [DOI: 10.1007/bf03321480] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
175 Mearin F, Lanas Á, Bujanda L, Canelles P, Cotter J, Hervás A, Martín de Argila C, Montoro M, Gisbert JP. Open questions and misconceptions in the diagnosis and management of anemia in patients with gastrointestinal bleeding. Gastroenterol Hepatol 2018;41:63-76. [PMID: 29107389 DOI: 10.1016/j.gastrohep.2017.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
176 Palchaudhuri S, Albenberg L, Lewis JD. Diet Recommendations for Hospitalized Patients With Inflammatory Bowel Disease: Better Options Than Nil Per Os. Crohns Colitis 360 2020;2:otaa059. [PMID: 33954288 DOI: 10.1093/crocol/otaa059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
177 Kamath N, Pai CG, Deltombe T. Pure red cell aplasia due to azathioprine therapy for Crohn's disease. Indian J Pharmacol 2016;48:86-7. [PMID: 26997730 DOI: 10.4103/0253-7613.174569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
178 Polin V, Coriat R, Perkins G, Dhooge M, Abitbol V, Leblanc S, Prat F, Chaussade S. Iron deficiency: from diagnosis to treatment. Dig Liver Dis 2013;45:803-9. [PMID: 23582772 DOI: 10.1016/j.dld.2013.02.019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
179 Kedia S, Ahuja V, Tandon R. Management of acute severe ulcerative colitis. World J Gastrointest Pathophysiol 2014; 5(4): 579-588 [PMID: 25401001 DOI: 10.4291/wjgp.v5.i4.579] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
180 Schmidt C, Ahmad T, Tulassay Z, Baumgart DC, Bokemeyer B, Howaldt S, Stallmach A, Büning C; AEGIS Study Group. Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study. Aliment Pharmacol Ther 2016;44:259-70. [PMID: 27237709 DOI: 10.1111/apt.13665] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
181 Gargallo-Puyuelo CJ, Alfambra E, García-Erce JA, Gomollon F. Iron Treatment May Be Difficult in Inflammatory Diseases: Inflammatory Bowel Disease as a Paradigm. Nutrients 2018;10:E1959. [PMID: 30544934 DOI: 10.3390/nu10121959] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
182 Stein J, Connor S, Virgin G, Ong DEH, Pereyra L. Anemia and iron deficiency in gastrointestinal and liver conditions. World J Gastroenterol 2016; 22(35): 7908-7925 [PMID: 27672287 DOI: 10.3748/wjg.v22.i35.7908] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 40] [Article Influence: 9.7] [Reference Citation Analysis]
183 Rodríguez-Moranta F, Rodríguez-Alonso L, Guardiola Capón J. [Approach to the diagnosis and treatment of chronic anemia secondary to gastrointestinal diseases]. Gastroenterol Hepatol 2014;37:573-82. [PMID: 25443541 DOI: 10.1016/j.gastrohep.2014.07.009] [Reference Citation Analysis]
184 Reinisch W, Chowers Y, Danese S, Dignass A, Gomollón F, Nielsen OH, Lakatos PL, Lees CW, Lindgren S, Lukas M, Mantzaris GJ, Michetti P, Moum B, Peyrin-Biroulet L, Toruner M, van der Woude J, Weiss G, Stoevelaar H. The management of iron deficiency in inflammatory bowel disease--an online tool developed by the RAND/UCLA appropriateness method. Aliment Pharmacol Ther 2013;38:1109-18. [PMID: 24099472 DOI: 10.1111/apt.12493] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
185 de Alvarenga Antunes CV, de Alvarenga Nascimento CR, Campanha da Rocha Ribeiro T, de Alvarenga Antunes P, de Andrade Chebli L, Martins Gonçalves Fava L, Malaguti C, Maria Fonseca Chebli J. Treatment of iron deficiency anemia with liposomal iron in inflammatory bowel disease: efficacy and impact on quality of life. Int J Clin Pharm 2020;42:895-902. [PMID: 32367457 DOI: 10.1007/s11096-020-01044-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
186 Stein J, Walper A, Klemm W, Farrag K, Aksan A, Dignass A. Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice. Scand J Gastroenterol 2018;53:1059-65. [PMID: 30222479 DOI: 10.1080/00365521.2018.1498914] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
187 Bryant RV, Ooi S, Schultz CG, Goess C, Grafton R, Hughes J, Lim A, Bartholomeusz FD, Andrews JM. Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41:895-906. [PMID: 25753216 DOI: 10.1111/apt.13156] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
188 Peyrin-Biroulet L, Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr. 2015;102:1585-1594. [PMID: 26561626 DOI: 10.3945/ajcn.114.103366] [Cited by in Crossref: 113] [Cited by in F6Publishing: 92] [Article Influence: 16.1] [Reference Citation Analysis]
189 Muñoz M, Martín-montañez E. Ferric carboxymaltose for the treatment of iron-deficiency anemia. Expert Opinion on Pharmacotherapy 2012;13:907-21. [DOI: 10.1517/14656566.2012.669373] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
190 Battat R, Kopylov U, Byer J, Sewitch MJ, Rahme E, Nedjar H, Zelikovic E, Dionne S, Bessissow T, Afif W, Waters PJ, Seidman E, Bitton A. Vitamin B12 deficiency in inflammatory bowel disease: a prospective observational pilot study. European Journal of Gastroenterology & Hepatology 2017;29:1361-7. [DOI: 10.1097/meg.0000000000000970] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
191 Kaitha S, Bashir M, Ali T. Iron deficiency anemia in inflammatory bowel disease. World J Gastrointest Pathophysiol 2015; 6(3): 62-72 [PMID: 26301120 DOI: 10.4291/wjgp.v6.i3.62] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 49] [Article Influence: 7.7] [Reference Citation Analysis]
192 Auerbach M, Henry D, Derman RJ, Achebe MM, Thomsen LL, Glaspy J. A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial. Am J Hematol 2019;94:1007-14. [PMID: 31243803 DOI: 10.1002/ajh.25564] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
193 Bengi G, Keyvan H, Durmaz SB, Akpınar H. Frequency, types, and treatment of anemia in Turkish patients with inflammatory bowel disease. World J Gastroenterol 2018; 24(36): 4186-4196 [PMID: 30271083 DOI: 10.3748/wjg.v24.i36.4186] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
194 Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, Hjollund NH, Dahlerup JF. Fatigue in out-patients with inflammatory bowel disease is common and multifactorial. Aliment Pharmacol Ther. 2012;35:133-141. [PMID: 22059387 DOI: 10.1111/j.1365-2036.2011.04914.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 5.8] [Reference Citation Analysis]
195 Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015;10:e0117383. [PMID: 25700159 DOI: 10.1371/journal.pone.0117383] [Cited by in Crossref: 236] [Cited by in F6Publishing: 206] [Article Influence: 33.7] [Reference Citation Analysis]
196 Powell JJ, Cook WB, Chatfield M, Hutchinson C, Pereira DIa, Lomer MC. Iron status is inversely associated with dietary iron intakes in patients with inactive or mildly active inflammatory bowel disease. Nutr Metab (Lond) 2013;10:18. [PMID: 23374396 DOI: 10.1186/1743-7075-10-18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
197 Nagao S, Taguchi K, Miyazaki Y, Wakayama T, Chuang VT, Yamasaki K, Watanabe H, Sakai H, Otagiri M, Maruyama T. Evaluation of a new type of nano-sized carbon monoxide donor on treating mice with experimentally induced colitis. J Control Release 2016;234:49-58. [PMID: 27173944 DOI: 10.1016/j.jconrel.2016.05.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
198 König P, Jimenez K, Saletu-zyhlarz G, Mittlböck M, Gasche C. Iron deficiency, depression, and fatigue in inflammatory bowel diseases. Z Gastroenterol 2020;58:1191-200. [DOI: 10.1055/a-1283-6832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
199 Abegunde AT, Muhammad BH, Ali T. Preventive health measures in inflammatory bowel disease. World J Gastroenterol 2016; 22(34): 7625-7644 [PMID: 27678347 DOI: 10.3748/wjg.v22.i34.7625] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
200 Çekiç C, İpek S, Aslan F, Akpınar Z, Arabul M, Topal F, Sarıtaş Yüksel E, Alper E, Ünsal B. The effect of intravenous iron treatment on quality of life in inflammatory bowel disease patients with nonanemic iron deficiency. Gastroenterol Res Pract 2015;2015:582163. [PMID: 25691898 DOI: 10.1155/2015/582163] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
201 Koutroubakis IE, Oustamanolakis P, Karakoidas C, Mantzaris GJ, Kouroumalis EA. Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease. Dig Dis Sci. 2010;55:2327-2331. [PMID: 19834803 DOI: 10.1007/s10620-009-1022-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
202 Laass MW, Straub S, Chainey S, Virgin G, Cushway T. Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases. BMC Gastroenterol 2014;14:184. [PMID: 25326048 DOI: 10.1186/1471-230X-14-184] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
203 Frohlich DO, Birnbrauer K. Discrepancies in health information found on web sites discussing cures for inflammatory bowel disease, an "incurable" disease. Inflamm Bowel Dis 2014;20:458-63. [PMID: 24487273 DOI: 10.1097/01.MIB.0000442013.45038.47] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
204 Keating GM. Ferric Carboxymaltose: A Review of Its Use in Iron Deficiency. Drugs 2015;75:101-27. [DOI: 10.1007/s40265-014-0332-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 6.9] [Reference Citation Analysis]
205 Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H, Dahlerup JF. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scandinavian Journal of Gastroenterology 2011;46:304-9. [DOI: 10.3109/00365521.2010.533382] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
206 Kalra PA, Bhandari S. Efficacy and safety of iron isomaltoside (Monofer(®)) in the management of patients with iron deficiency anemia. Int J Nephrol Renovasc Dis 2016;9:53-64. [PMID: 27022297 DOI: 10.2147/IJNRD.S89704] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
207 Foteinogiannopoulou K, Karmiris K, Axiaris G, Velegraki M, Gklavas A, Kapizioni C, Karageorgos C, Kateri C, Katsoula A, Kokkotis G, Koureta E, Lamouri C, Markopoulos P, Palatianou M, Pastras P, Fasoulas K, Giouleme O, Zampeli E, Theodoropoulou A, Theocharis G, Thomopoulos K, Karatzas P, Katsanos KH, Kapsoritakis A, Kourikou A, Mathou N, Manolakopoulos S, Michalopoulos G, Michopoulos S, Boubonaris A, Bamias G, Papadopoulos V, Papatheodoridis G, Papaconstantinou I, Pachiadakis I, Soufleris K, Tzouvala M, Triantos C, Tsironi E, Christodoulou DK, Koutroubakis IE; Hellenic group for the study of IBD. The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study. BMC Gastroenterol 2021;21:269. [PMID: 34187376 DOI: 10.1186/s12876-021-01826-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Akhuemonkhan E, Parian A, Carson KA, Hutfless S. Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010-2014. Inflamm Bowel Dis 2018;24:1801-7. [PMID: 29669068 DOI: 10.1093/ibd/izy063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
209 Biancone L, Michetti P, Travis S, Escher JC, Moser G, Forbes A, Hoffmann JC, Dignass A, Gionchetti P, Jantschek G, Kiesslich R, Kolacek S, Mitchell R, Panes J, Soderholm J, Vucelic B, Stange E. European evidence-based Consensus on the management of ulcerative colitis: Special situations. Journal of Crohn's and Colitis 2008;2:63-92. [DOI: 10.1016/j.crohns.2007.12.001] [Cited by in Crossref: 168] [Cited by in F6Publishing: 127] [Article Influence: 12.0] [Reference Citation Analysis]
210 Qureshi T, Peter Nguyen T, Wang R, Willis D, Shah R, Hou JK. Improving Anemia in Inflammatory Bowel Disease: Impact of the Anemia Care Pathway. Dig Dis Sci 2019;64:2124-31. [PMID: 30879168 DOI: 10.1007/s10620-019-05559-w] [Reference Citation Analysis]
211 Eriksson C, Henriksson I, Brus O, Zhulina Y, Nyhlin N, Tysk C, Montgomery S, Halfvarson J. Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population-based cohort study. Aliment Pharmacol Ther. 2018;48:638-645. [PMID: 30069892 DOI: 10.1111/apt.14920] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
212 Hwa YL, Rashtak S, Kelly DG, Murray JA. Iron Deficiency in Long-Term Parenteral Nutrition Therapy. JPEN J Parenter Enteral Nutr. 2016;40:869-876. [PMID: 25972429 DOI: 10.1177/0148607115587329] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
213 Meybohm P, Muellenbach RM, Keller H, Fichtlscherer S, Papadopoulos N, Spahn DR, Greinacher A, Zacharowski K. Patient Blood Management in der Herzchirurgie. Z Herz- Thorax- Gefäßchir 2017;31:247-65. [DOI: 10.1007/s00398-017-0168-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
214 Mearin F, Balboa A, Castells A, Domínguez JE, Esteve M, García-erce JA, Pérez Gisbert J, Gomollón F, Panés J, Ponce J. Anemia ferropénica y uso de hierro endovenoso en patología digestiva. Gastroenterología y Hepatología 2010;33:605-13. [DOI: 10.1016/j.gastrohep.2010.08.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
215 Goldberg ND. Iron deficiency anemia in patients with inflammatory bowel disease. Clin Exp Gastroenterol 2013;6:61-70. [PMID: 23766655 DOI: 10.2147/CEG.S43493] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
216 González Alayón C, Pedrajas Crespo C, Marín Pedrosa S, Benítez JM, Iglesias Flores E, Salgueiro Rodríguez I, Medina Medina R, García-sánchez V. Prevalencia de déficit de hierro sin anemia en la enfermedad inflamatoria intestinal y su impacto en la calidad de vida. Gastroenterología y Hepatología 2018;41:22-9. [DOI: 10.1016/j.gastrohep.2017.07.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
217 Stein J, Dignass AU. Anaemia in the Elderly IBD Patient. Curr Treat Options Gastroenterol. 2015;13:308-318. [PMID: 26164616 DOI: 10.1007/s11938-015-0062-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
218 Stallmach A, Büning C. Ferric maltol (ST10): a novel oral iron supplement for the treatment of iron deficiency anemia in inflammatory bowel disease. Expert Opin Pharmacother 2015;16:2859-67. [PMID: 26595432 DOI: 10.1517/14656566.2015.1096929] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
219 van Langenberg DR, Gibson PR. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther. 2010;32:131-143. [PMID: 20456309 DOI: 10.1111/j.1365-2036.2010.04347.x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 105] [Article Influence: 9.3] [Reference Citation Analysis]
220 Pels LP, Van de Vijver E, Waalkens HJ, Uitentuis J, JGonera-de ong G, van Overbeek LA, Norbruis OF, Rings EH, van Rheenen PF. Slow hematological recovery in children with IBD-associated anemia in cases of "expectant management". J Pediatr Gastroenterol Nutr. 2010;51:708-713. [PMID: 20683207 DOI: 10.1097/mpg.0b013e3181da4d8b] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
221 Yueying C, Yu Fan W, Jun S. Anemia and iron deficiency in Crohn's disease. Expert Rev Gastroenterol Hepatol 2020;14:155-62. [PMID: 32077335 DOI: 10.1080/17474124.2020.1732817] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
222 Cotter J, Baldaia C, Ferreira M, Macedo G, Pedroto I. Diagnosis and treatment of iron-deficiency anemia in gastrointestinal bleeding: A systematic review. World J Gastroenterol 2020; 26(45): 7242-7257 [PMID: 33362380 DOI: 10.3748/wjg.v26.i45.7242] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
223 Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, Lam CS, Macdougall IC, Rogler G, Camaschella C, Kadir R, Kassebaum NJ, Spahn DR, Taher AT, Musallam KM; IRON CORE Group. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol 2017;92:1068-78. [PMID: 28612425 DOI: 10.1002/ajh.24820] [Cited by in Crossref: 137] [Cited by in F6Publishing: 111] [Article Influence: 27.4] [Reference Citation Analysis]
224 Maniatis A. The role of iron in anaemia management: can intravenous iron contribute to blood conservation? ISBT Science Series 2008;3:139-43. [DOI: 10.1111/j.1751-2824.2008.00149.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
225 Nielsen OH, Soendergaard C, Vikner ME, Weiss G. Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease. Nutrients 2018;10:E82. [PMID: 29342861 DOI: 10.3390/nu10010082] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
226 Gomollón F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastroenterol 2009; 15(37): 4659-4665 [PMID: 19787829 DOI: 10.3748/wjg.15.4659] [Cited by in CrossRef: 112] [Cited by in F6Publishing: 102] [Article Influence: 8.6] [Reference Citation Analysis]
227 Chen X, Tang ZP. Traditional Chinese medicine combined with Western medicine for diagnosis and treatment of ulcerative colitis with anemia. Shijie Huaren Xiaohua Zazhi 2016; 24(23): 3502-3507 [DOI: 10.11569/wcjd.v24.i23.3502] [Reference Citation Analysis]
228 Khan N, Patel D, Shah Y, Yang Y. A Novel Model for Predicting Incident Moderate to Severe Anemia and Iron Deficiency in Patients with Newly Diagnosed Ulcerative Colitis. Dig Dis Sci 2017;62:1295-304. [DOI: 10.1007/s10620-017-4512-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
229 Foy SP, Labhasetwar V. Oh the irony: Iron as a cancer cause or cure? Biomaterials 2011;32:9155-8. [PMID: 21963282 DOI: 10.1016/j.biomaterials.2011.09.047] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
230 Coyne DW, Auerbach M. Anemia management in chronic kidney disease: intravenous iron steps forward. Am J Hematol 2010;85:311-2. [PMID: 20232350 DOI: 10.1002/ajh.21682] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
231 Nielsen OH, Ainsworth M, Coskun M, Weiss G. Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review. Medicine (Baltimore) 2015;94:e963. [PMID: 26061331 DOI: 10.1097/MD.0000000000000963] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 6.1] [Reference Citation Analysis]
232 Papadopoulos M, Patel D, Korologou-Linden R, Goto E, Soondrum K, Fell JME, Epstein J. Safety and efficacy of parenteral iron in children with inflammatory bowel disease. Br J Clin Pharmacol 2018;84:694-9. [PMID: 29266387 DOI: 10.1111/bcp.13493] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
233 Gomollón F, Gisbert JP. Intravenous iron in inflammatory bowel diseases. Curr Opin Gastroenterol 2013;29:201-7. [PMID: 23274316 DOI: 10.1097/MOG.0b013e32835bdc2e] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
234 Lightner AL, Shen B. Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new "biological era". Gastroenterol Rep (Oxf) 2017;5:165-77. [PMID: 28852521 DOI: 10.1093/gastro/gow046] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
235 Keeler BD, Krell J, Acheson AG, Brookes MJ, Stebbing J, Frampton AE. Is there a role for intravenous iron therapy in patients undergoing colorectal cancer resection? Expert Rev Anticancer Ther 2012;12:1407-12. [PMID: 23249105 DOI: 10.1586/era.12.122] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
236 Han YM, Yoon H, Shin CM, Koh SJ, Im JP, Kim BG, Kim JS, Jung HC. Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea. Gut Liver 2016;10:562-8. [PMID: 27021505 DOI: 10.5009/gnl15373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
237 Bou-Fakhredin R, Halawi R, Roumi J, Taher A. Insights into the diagnosis and management of iron deficiency in inflammatory bowel disease. Expert Rev Hematol 2017;10:801-8. [PMID: 28701106 DOI: 10.1080/17474086.2017.1355233] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
238 Wu Q, Lai X, Zhao H, Zhu Z, Hong Z, Guo Z, Chai Y. A metabolomics approach for predicting the response to intravenous iron therapy in peritoneal dialysis patients with anemia. RSC Adv 2017;7:1915-22. [DOI: 10.1039/c6ra24152b] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
239 Carter D, Bardan E, Derazne E, Tzur D, Avidan B. The incidence of gastrointestinal pathology and subsequent anemia in young men presenting with iron deficiency without anemia: . European Journal of Gastroenterology & Hepatology 2016;28:1126-9. [DOI: 10.1097/meg.0000000000000687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
240 Azzopardi N, Ellul P. Iron deficiency in Crohn's disease: Iron supplementation or disease control? Journal of Crohn's and Colitis 2014;8:1333. [DOI: 10.1016/j.crohns.2014.03.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
241 Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2009;2:2. [PMID: 19133145 DOI: 10.1186/1755-8794-2-2] [Cited by in Crossref: 317] [Cited by in F6Publishing: 302] [Article Influence: 24.4] [Reference Citation Analysis]
242 Goodhand JR, Kamperidis N, Rao A, Laskaratos F, McDermott A, Wahed M, Naik S, Croft NM, Lindsay JO, Sanderson IR, Rampton DS. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:513-519. [PMID: 21604328 DOI: 10.1002/ibd.21740] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 7.5] [Reference Citation Analysis]
243 Brain O, Travis SP. Therapy of ulcerative colitis: state of the art: . Current Opinion in Gastroenterology 2008;24:469-74. [DOI: 10.1097/mog.0b013e3282ff0dd5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
244 Mücke V, Mücke MM, Raine T, Bettenworth D. Diagnosis and treatment of anemia in patients with inflammatory bowel disease. Ann Gastroenterol 2017;30:15-22. [PMID: 28042234 DOI: 10.20524/aog.2016.0083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
245 Murawska N, Fabisiak A, Fichna J. Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases: Pathophysiology, Diagnosis, and Treatment. Inflamm Bowel Dis. 2016;22:1198-1208. [PMID: 26818422 DOI: 10.1097/mib.0000000000000648] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 6.8] [Reference Citation Analysis]
246 Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010;7:599-610. [PMID: 20924367 DOI: 10.1038/nrgastro.2010.151] [Cited by in Crossref: 129] [Cited by in F6Publishing: 130] [Article Influence: 10.8] [Reference Citation Analysis]
247 Goldenberg BA, Graff LA, Clara I, Zarychanski R, Walker JR, Carr R, Rogala L, Miller N, Bernstein CN. Is iron deficiency in the absence of anemia associated with fatigue in inflammatory bowel disease? Am J Gastroenterol. 2013;108:1392-1397. [PMID: 24005345 DOI: 10.1038/ajg.2013.14] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
248 Wikholm E, Malmborg P, Forssberg M, Hederos CA, Wikström S. Iron Deficiency Is Common During Remission in Children With Inflammatory Bowel Disease. Glob Pediatr Health 2016;3:2333794X16633672. [PMID: 27336004 DOI: 10.1177/2333794X16633672] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
249 Antunes CV, Hallack Neto AE, Nascimento CR, Chebli LA, Moutinho IL, Pinheiro Bdo V, Reboredo MM, Malaguti C, Castro AC, Chebli JM. Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology. Biomed Res Int. 2015;2015:728925. [PMID: 25705682 DOI: 10.1155/2015/728925] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
250 Katsanos AH, Katsanos KH, Kosmidou M, Giannopoulos S, Kyritsis AP, Tsianos EV. Cerebral sinus venous thrombosis in inflammatory bowel diseases. QJM. 2013;106:401-413. [PMID: 23243293 DOI: 10.1093/qjmed/hcs229] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
251 Lomer MC. Dietary and nutritional considerations for inflammatory bowel disease. Proc Nutr Soc. 2011;70:329-335. [PMID: 21450124 DOI: 10.1017/s0029665111000097] [Cited by in Crossref: 48] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
252 Bhandari S. A hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000. Ther Clin Risk Manag 2011;7:103-13. [PMID: 21479141 DOI: 10.2147/TCRM.S17536] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
253 Goodhand JR, Kamperidis N, Joshi NM, Wahed M, Koodun Y, Cantor EJ, Croft NM, Langmead FL, Lindsay JO, Rampton DS. The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descent. Aliment Pharmacol Ther. 2012;35:929-940. [PMID: 22404452 DOI: 10.1111/j.1365-2036.2012.05043.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
254 Ott C, Schölmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10:585-595. [PMID: 23835489 DOI: 10.1038/nrgastro.2013.117] [Cited by in Crossref: 124] [Cited by in F6Publishing: 115] [Article Influence: 13.8] [Reference Citation Analysis]
255 Miller SD, Cuffari C, Akhuemonkhan E, Guerrerio AL, Lehmann H, Hutfless S. Anemia Screening, Prevalence, and Treatment in Pediatric Inflammatory Bowel Disease in the United States, 2010-2014. Pediatr Gastroenterol Hepatol Nutr 2019;22:152-61. [PMID: 30899691 DOI: 10.5223/pghn.2019.22.2.152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
256 Carvalho FSG, de Medeiros IA, Antunes H. Prevalence of iron deficiency anemia and iron deficiency in a pediatric population with inflammatory bowel disease. Scand J Gastroenterol 2017;52:1099-103. [PMID: 28643539 DOI: 10.1080/00365521.2017.1342137] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
257 Lomer MC, Cook WB, Jan-Mohamed HJ, Hutchinson C, Liu DY, Hider RC, Powell JJ. Iron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel disease. Br J Nutr. 2012;107:1806-1811. [PMID: 22152498 DOI: 10.1017/s0007114511004971] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
258 Khan N, Patel D, Shah Y, Lichtenstein G, Yang Y. A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis: . Inflammatory Bowel Diseases 2017;23:991-7. [DOI: 10.1097/mib.0000000000001080] [Cited by in Crossref: 6] [Article Influence: 1.2] [Reference Citation Analysis]
259 Wong T. Parenteral trace elements in children: clinical aspects and dosage recommendations. Current Opinion in Clinical Nutrition and Metabolic Care 2012;15:649-56. [DOI: 10.1097/mco.0b013e3283582187] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
260 Kulnigg S, Teischinger L, Dejaco C, Waldhör T, Gasche C. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Am J Gastroenterol. 2009;104:1460-1467. [PMID: 19491860 DOI: 10.1038/ajg.2009.114] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 5.0] [Reference Citation Analysis]
261 Battat R, Kopylov U, Szilagyi A, Saxena A, Rosenblatt DS, Warner M, Bessissow T, Seidman E, Bitton A. Vitamin B12 deficiency in inflammatory bowel disease: prevalence, risk factors, evaluation, and management. Inflamm Bowel Dis 2014;20:1120-8. [PMID: 24739632 DOI: 10.1097/MIB.0000000000000024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
262 Koutroubakis IE, Ramos-Rivers C, Regueiro M, Koutroumpakis E, Click B, Schwartz M, Swoger J, Baidoo L, Hashash JG, Barrie A. Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort. J Clin Gastroenterol. 2016;50:638-643. [PMID: 26485103 DOI: 10.1097/mcg.0000000000000417] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
263 Derman R, Roman E, Smith-Nguyen GN, Achebe MM, Thomsen LL, Auerbach M. Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia. Am J Hematol 2018;93:E148-50. [PMID: 29569727 DOI: 10.1002/ajh.25094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
264 Bailie GR, Larkina M, Goodkin DA, Li Y, Pisoni RL, Bieber B, Mason N, Tong L, Locatelli F, Marshall MR, Inaba M, Robinson BM. Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2013;28:2570-9. [PMID: 24078642 DOI: 10.1093/ndt/gft062] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 8.1] [Reference Citation Analysis]
265 Oustamanolakis P, Koutroubakis IE, Messaritakis I, Kefalogiannis G, Niniraki M, Kouroumalis EA. Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease. Journal of Crohn's and Colitis 2011;5:295-300. [DOI: 10.1016/j.crohns.2011.02.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
266 Hou JK, Gasche C, Drazin NZ, Weaver SA, Ehrlich OG, Oberai R, Zapala S, Siegel CA, Melmed G. Assessment of Gaps in Care and the Development of a Care Pathway for Anemia in Patients with Inflammatory Bowel Diseases. Inflamm Bowel Dis 2017;23:35-43. [PMID: 27749376 DOI: 10.1097/MIB.0000000000000953] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
267 Chi SI. Complications caused by nitrous oxide in dental sedation. J Dent Anesth Pain Med 2018;18:71-8. [PMID: 29744381 DOI: 10.17245/jdapm.2018.18.2.71] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
268 Holm C, Thomsen LL, Langhoff-Roos J. Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage. J Matern Fetal Neonatal Med 2019;32:2797-804. [PMID: 29558233 DOI: 10.1080/14767058.2018.1449205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]